Circulating prolactin and in situ breast cancer risk in the European EPIC cohort: A case-control study

Kaja Tikk*, Disorn Sookthai, Renée T. Fortner, Theron Johnson, Sabina Rinaldi, Isabelle Romieu, Anne Tjønneland, Anja Olsen, Kim Overvad, Françoise Clavel-Chapelon, Laura Baglietto, Heiner Boeing, Antonia Trichopoulou, Pagona Lagiou, Dimitrios Trichopoulos, Giovanna Masala, Vittorio Krogh, Rosario Tumino, Fulvio Ricceri, Amalia MattielloAntonio Agudo, Virginia Menéndez, María José Sánchez, Pilar Amiano, Maria Dolores Chirlaque, Aurelio Barricarte, Hbas Bueno-de-Mesquita, Evelyn M. Monninkhof, N. Charlotte Onland-Moret, Anne Andresson, Malin Sund, Elisabete Weiderpass, Kay Tee Khaw, Timothy J. Key, Ruth C. Travis, Melissa A. Merritt, Elio Riboli, Laure Dossus, Rudolf Kaaks

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'Circulating prolactin and in situ breast cancer risk in the European EPIC cohort: A case-control study'. Together they form a unique fingerprint.

Medicine & Life Sciences